Burning Rock Biotech Limited
BNR
$2.90
-$0.04-1.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 37.19% | 37.19% | 36.30% |
| Total Depreciation and Amortization | -- | -- | 7.14% | 7.14% | 7.14% |
| Total Amortization of Deferred Charges | -- | -- | -42.75% | -42.75% | -42.75% |
| Total Other Non-Cash Items | -- | -- | -13.95% | -13.95% | -26.46% |
| Change in Net Operating Assets | -- | -- | -359.99% | -359.99% | -359.99% |
| Cash from Operations | -- | -- | 58.86% | 58.86% | 46.64% |
| Capital Expenditure | -- | -- | 88.65% | 88.65% | 88.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -96.59% | -96.59% | -96.59% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -99.59% | -99.59% | -102.59% |
| Cash from Investing | -- | -- | -363.02% | -363.02% | -26.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 90.29% | 90.29% | 90.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -414.24% | -414.24% | -247.78% |
| Cash from Financing | -- | -- | 45.37% | 45.37% | 47.93% |
| Foreign Exchange rate Adjustments | -- | -- | -75.65% | -75.65% | -89.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 53.39% | 53.39% | 42.78% |